Search Within

Lisa Bodei

  1. "Simone Krebs"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (4)
Groups
  1. Molecular Imaging and Therapy Service (10)
  2. Radiology, Department of (10)
  3. Sloan Kettering Institute Postdocs (10)
  4. Center for Pancreatic Cancer Research (8)
  5. Department of Medicine (8)
  6. Gastrointestinal Oncology Service (8)

More Groups

People
  1. Simone Krebs (10)
  2. Diane Reidy (8)
  3. Joseph O'Donoghue (5)
  4. Neeta Pandit-Taskar (5)
  5. Nitya Raj (5)
  6. Wolfgang Weber (5)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (1)
  4. 2021 (1)
  5. 2020 (1)
  6. 2019 (2)

More Years

Publications
  1. European Journal of Nuclear Medicine and Molecular Imaging (5)
  2. Journal of Nuclear Medicine (2)
  3. Pancreas (2)
  4. Clinical Cancer Research (1)
Publishers
  1. Springer (5)
  2. Lippincott Williams & Wilkins (2)
  3. Society of Nuclear Medicine (2)
  4. American Association for Cancer Research (1)

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Development of PET response criteria in neuroendocrine tumors (PERCIN)
    Meeting Abstract

    Chaban, A.; Dinkel, V.; Eiber, M.; Song, Y.; Brosch-Lenz, J.; Krebs, S.; Bodei, L.; Weber, W.
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • Development of a semi-automatic platform for whole body tumor segmentation and radiomic feature extraction from 68Ga-DOTATATE PET/CT using TriDFusion (3DF)
    Meeting Abstract

    Krebs, S.; Lafontaine, D.; Bodei, L.; Mayerhoefer, M. E.; Humm, J.; Schöder, H.
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Interim analysis of a prospective validation of 2 blood-based genomic assessments (PPQ and NETest) to determine the clinical efficacy of (177)Lu-DOTATATE in neuroendocrine tumors
    Journal Article

    Bodei, L.; Raj, N.; Do, R. K.; Mauguen, A.; Krebs, S.; Reidy-Lagunes, D.; Schöder, H.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Blood-based genomic assessment of clinical efficacy and toxicity of (177)Lu-DOTATATE of neuroendocrine tumors
    Meeting Abstract

    Bodei, L.; Raj, N.; Do, K. G.; Krebs, S.; Reidy-Lagunes, D.; Kidd, M.; Drozdov, I.; Modlin, I.; Schöder, H.
    Pancreas (2022)

    Fulltext@MSK | Save
  • Blood based genomic assessment of the clinical efficacy and toxicity of peptide receptor radionuclide therapy (PRRT)
    Meeting Abstract

    Bodei, L.; Raj, N.; Do, R. K. G.; Krebs, S.; Reidy, D.; Kidd, M.; Drozdov, I.; Modlin, I.; Schoder, H.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • Comparison of (68)Ga-DOTA-JR11 PET/CT with dosimetric (177)Lu-satoreotide tetraxetan ((177)Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy
    Journal Article

    Krebs, S.; O'Donoghue, J. A.; Biegel, E.; Beattie, B. J.; Reidy, D.; Lyashchenko, S. K.; Lewis, J. S.; Bodei, L.; Weber, W. A.; Pandit-Taskar, N.
    European Journal of Nuclear Medicine and Molecular Imaging (2020)

    Fulltext@MSK | Save
  • Phase I trial of well-differentiated neuroendocrine tumors (NETs) with radiolabeled somatostatin antagonist (177)Lu-satoreotide tetraxetan
    Journal Article

    Reidy-Lagunes, D.; Pandit-Taskar, N.; O'Donoghue, J. A.; Krebs, S.; Staton, K. D.; Lyashchenko, S. K.; Lewis, J. S.; Raj, N.; Gönen, M.; Lohrmann, C.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Biodistribution and radiation dose estimates for (68)Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors
    Journal Article

    Krebs, S.; Pandit-Taskar, N.; Reidy, D.; Beattie, B. J.; Lyashchenko, S. K.; Lewis, J. S.; Bodei, L.; Weber, W. A.; O'Donoghue, J. A.
    European Journal of Nuclear Medicine and Molecular Imaging (2019)

    Fulltext@MSK | Save
  • Comparison of (68)Ga-DOTA-JR11 PET/CT with (dosimetric) (177)Lu-DOTA-JR11 SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy
    Meeting Abstract

    Krebs, S.; O'Donoghue, J.; Biegel, E.; Beattie, B. J.; Reidy, D.; Bodei, L.; Weber, W. A.; Pandit-Taskar, N.
    European Journal of Nuclear Medicine and Molecular Imaging (2018)

    Fulltext@MSK | Save
  • Theranostic trial of well differentiated neuroendocrine tumors (NETs) with 68Ga-OPS201 and 177Lu-OPS201
    Meeting Abstract

    Reidy-Lagunes, D.; Pandit-Taskar, N.; Krebs, S.; O'Donoghue, J.; Raj, N. P.; Cruz, E.; Pham, H.; Lashley, A.; Bodei, L.; Weber, W.
    Pancreas (2018)

    Fulltext@MSK | Save